Montelukast in children with chronic persistent asthma IL-2 tumor necrosis factor and pulmonary function.docVIP

Montelukast in children with chronic persistent asthma IL-2 tumor necrosis factor and pulmonary function.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Montelukast in children with chronic persistent asthma IL-2 tumor necrosis factor and pulmonary function

 PAGE \* MERGEFORMAT 7 Montelukast in children with chronic persistent asthma IL-2 tumor necrosis factor and pulmonary function [Abstract] montelukast can reduce airway hyperresponsiveness, strengthen the immune factor IL-2, reduced levels of tumor necrosis factor induced by inflammation, regulating Th1 / Th2 balance. [Keywords:] montelukast IL-2 tumor necrosis factor on lung function in children with chronic persistent Pediatric hospital in October 2008 -2009 application on October montelukast sodium treatment of children with asthma, chronic persistent asthma control achieved in children with good clinical efficacy and inflammatory mediators and molecular biology from the level of the drug’s mechanism of action. 1 Materials and Methods 1.1 The source of all the cases observed in 52 cases patients were from Shandong Laiwu City People’s Hospital pediatric asthma clinic, all the observed cases are in line with the National Pediatric Asthma Collaborative Group 2008 revised diagnostic criteria of asthma, staging and disease indexing. All children with chronic illness are in duration. including 29 males and 23 females, aged 3 years to 12 years, duration 3 to 12 months. All the patients before treatment, blood, liver and kidney functions were normal cases were randomly divided .52 for the treatment group of 30 patients, 22 patients in control group. two children in the sex, age by the statistical difference was not statistically significant (Pgt; 0.05, comparable. 1.2 The control group of drug dosage and route of a single glucocorticoid (ICS) inhalation, given budesonide (AstraZeneca inhalation, 200ug / time, 2 times / day, later changed to symptom control 200ug / time, 1 time / day or every other day 1, told his mouth after smoking. the treatment group given inhaled corticosteroids based on the addition of montelukast sodium (Hangzhou MSD Pharmaceutical Co., Ltd., 3 5-year-old 4mg / times, 6 to 12 years old 5mg / times, 1 times / day

您可能关注的文档

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档